| View |
|
DRP-15878
|
Alpha Keto analogues + Essential Amino Acids
|
Ketonova
|
Each film coated tablet contains:
Calcium-3-methyl-2-oxo-valerate (a-ketoanalogue to isoleucine, calcium salt).
Calcium-4-methyl-2-oxo-valerate (a-ketoanalogue to leucine, calcium salt)...
Calcium-2-oxo-3-phenylpropionate (a-ketoanalogue to phenylalanine, calcium salt)...........
Calcium-3-methyl-2-oxo-butyrate (a-ketoanalogue to valine, calcium salt)..
Calcium-dl-2-hydroxy-4(methylthio) butyrate (a-hydroxyanalogue to methionine, calcium
salt).....
L-Lysine acetate USP (corresponding to 75 mg L lysine).......
L-Threonine USP.....
L-Tryptophan USP.
L-Histidine USP.....
L-Tyrosine USP.
Excipients.....
Colour.....
pacpy osat xx
67 mg 101 mg
68 mg
86 mg
59 mg
105 mg
53 mg
23 mg
38 mg
30 mg
q.s
Quinoline yellow
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Saga Lifesciences Limited
|
India
|
Initial
|
25 September 2024
|
25 September 2029
|
| View |
|
DRP-15841
|
Atorvastatin (as calcium)
|
Ftor
|
10 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG COA Reductase Inhibitor)
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
20 September 2024
|
20 September 2029
|
| View |
|
DRP-15842
|
Atorvastatin (as calcium)
|
Ftor
|
20 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
20 September 2024
|
20 September 2029
|
| View |
|
DRP-15843
|
Atorvastatin (as calcium)
|
Ftor
|
40 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG COA Reductase Inhibitor)
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
20 September 2024
|
20 September 2029
|
| View |
|
DRP-15844
|
Atorvastatin (as calcium)
|
Ftor
|
80 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
20 September 2024
|
20 September 2029
|
| View |
|
DR-XY49221
|
Paliperidone (as palmitate)
|
Invega Hafyera
|
200 mg/mL (700 mg/3.5 mL)
|
Prolonged-Release Suspension for Injection (Gluteal I.M)
|
Antipsychotic
|
Janssen Pharmaceutica NV
|
Belgium
|
Monitored Release(MR)
|
23 September 2024
|
23 September 2029
|
| View |
|
DR-XY49222
|
Paliperidone (as palmitate)
|
Invega Hafyera
|
200 mg/mL (1 g/5 mL)
|
Prolonged-Release Suspension for Injection (Gluteal I.M.)
|
Antipsychotic
|
Janssen Pharmaceutica NV
|
Belgium
|
Monitored Release(MR)
|
23 September 2024
|
23 September 2029
|
| View |
|
DRP-15772
|
Cefepime (as hydrochloride)
|
Fepimed-1 Plus
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Cephalosporin)
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
Initial
|
20 September 2024
|
20 September 2029
|
| View |
|
DRP-15881
|
Metoclopramide (as hydrochloride)
|
Aepramide
|
5 mg/mL (10 mg/2 mL)
|
Solution for Injection (IM/IV)
|
Anti-emetic (Propulsive)
|
Shandong Qidu Pharmaceutical
|
China
|
Initial
|
25 September 2024
|
25 September 2029
|
| View |
|
DRP-15804
|
Pregabalin
|
Praxolin-75
|
75 mg
|
Capsule
|
Gabapentinoid
|
Baroque Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
26 September 2024
|
26 September 2029
|
| View |
|
DRP-15869
|
Oxaliplatin
|
OXAL SPAL-L 100
|
5 mg/mL (100 mg/20 mL)
|
Solution For Infusion
|
Antineoplastic
|
SP Accure Labs Pvt. Ltd.
|
India
|
Initial
|
25 September 2024
|
25 September 2029
|
| View |
|
DRP-15871
|
Oxaliplatin
|
Colox
|
50 mg
|
Lyophilized Powder for Injection (IV Infusion)
|
Antineoplastic
|
Cisen Pharmaceutical Co. Ltd.
|
China
|
Initial
|
25 September 2024
|
25 September 2029
|
| View |
|
DR-XY49223
|
Doxorubicin hydrochloride
|
Axbin
|
50 mg
|
Lyophilized Powder for Injection (I.V.)
|
Antineoplastic
|
Korea United Pharm. Inc.
|
Korea
|
Initial
|
24 September 2024
|
24 September 2029
|
| View |
|
DRP-15884
|
Calcipotriol (as monohydrate) + Betamethasone (as
dipropionate)
|
None
|
50 mcg/500 mcg
|
Topical Ointment
|
Anti-psoriatic
|
Asian Antibiotics, Inc.
|
Philippines
|
Initial
|
25 September 2024
|
25 September 2029
|
| View |
|
DRP-15870
|
Pantoprazole (as sodium)
|
Zaxid
|
40 mg
|
Delayed-Release Tablet
|
Proton Pump Inhibitor
|
Lincoln Pharmaceuticals Ltd.
|
India
|
Initial
|
25 September 2024
|
25 September 2029
|
| View |
|
DRP-15840
|
Febuxostat
|
Gourix
|
80 mg
|
Film-Coated Tablet
|
Antigout (Preparation including uric acid production)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
23 September 2024
|
23 September 2029
|
| View |
|
DRP-15894
|
Vildagliptin
|
Vilglad
|
50 mg
|
Tablet
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
Hetero Labs Limited (Unit V)
|
India
|
Initial
|
26 September 2024
|
26 September 2029
|
| View |
|
DRP-15896
|
Vildagliptin
|
Alvovilda
|
50 mg
|
Tablet
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
Intas Pharmaceuticals Limited
|
India
|
Initial
|
26 September 2024
|
26 September 2029
|
| View |
|
DRP-15895
|
Vildagliptin
|
Gliptus 50
|
50 mg
|
Tablet
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
Unison Laboratories Co., Ltd.
|
Thailand
|
Initial
|
26 September 2024
|
26 September 2029
|
| View |
|
DRP-15897
|
Vildagliptin + Metformin HC1
|
None
|
50 mg/1 g
|
Film-coated Tablet
|
Combination of oral blood glucose lowering drugs
|
BAFNA Pharmaceuticals Limited
|
India
|
Initial
|
26 September 2024
|
26 September 2029
|